Adipose tissue and its relation to inflammation: The role of adipokines

Journal of Renal Nutrition

Volumn 15, Issue 1, 2005, Pages 131-136

  Axelsson, Jonas ^a   Heimbürger, Olof ^a   Lindholm, Bengt ^a   Stenvinkel, Peter ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONFERENCE PAPER; ENERGY BALANCE; HEMODIALYSIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE; MUSCLE ATROPHY;

ADIPONECTIN; ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CYTOKINES; HUMANS; INFECTION; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEPTIN; OBESITY; RENAL DIALYSIS; RESISTIN; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WASTING SYNDROME;

EID: 11844278218     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2004.09.034     Document Type: Conference Paper

References (47)

1. P. Stenvinkel Inflammatory and atherosclerotic interactions in the depleted uremic patient Blood Purif 19 2001 53 61
2. P. Stenvinkel, O. Heimbürger, B. Lindholm Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome) Nephrol Dial Transplant 15 2000 953 960
3. A. Nawrocki, P.E. Scherer The delicate balance between fat and muscle Adipokines in metabolic disease and musculoskeletal inflammation Curr Opin Pharmacol 4 2004 281 289
4. E. Fleischmann, N. Teal, J. Dudley Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients Kidney Int 55 1999 1560 1567
5. J.D. Kopple, X. Zhu, N.L. Lew Body weight-for-height relationships predict mortality and morbidity in maintenance hemodialysis patients Kidney Int 56 1999 1136 1148
6. F.K. Port, V.B. Ashby, R.K. Dhingra Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients J Am Soc Nephrol 13 2002 1061 1066
7. P. Stenvinkel, O. Heimburger, B. Lindholm Wasting, but not malnutrition, predicts cardiovascular mortality in end-stage renal disease Nephrol Dial Transplant 19 2004 2181-2123
8. A. Morabia, A. Ross, F. Curtin Relation of BMI to a dual-energy X-ray absorptiometry measure of fatness Br J Nutr 82 1999 49 55
9. S. Beddhu, L.M. Pappas, N. Ramkumar Effects of body size and body composition on survival in hemodialysis patients J Am Soc Nephrol 14 2003 2366 2372
10. E.E. Kershaw, J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 2004 2548 2556
11. K. Kalantar-Zadeh, G. Block, M.H. Humphreys Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney Int 63 2003 793 808
12. D.S. Keith, G.A. Nichols, C.M. Gullion Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663
13. V. Mohamed-Ali, S. Goodrick, A. Rawesh Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factor-α, in vivo J Clin Endocrinol Metab 82 1997 4196 4200
14. K.E. Wellen, G.S. Hotamisligil Obesity-induced inflammatory changes in adipose tissue J Clin Invest 112 2003 1785 1788
15. M. Pedersen, H. Bruunsgaard, N. Weis Circulating levels of TNF-alpha and IL-6---relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes Mech Ageing Dev 124 2003 495 502
16. K. Esposito, A. Pontillo, C. Di Palo Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women A randomized trial JAMA 289 2003 1799 1804
17. P. Arner The adipocyte in insulin resistance Key molecules and the impact of the thiazolidinediones Trends Endocrinol Metab 14 2003 137 145
18. G. Atzmon, X.M. Yang, R. Muzumdar Differential gene expression between visceral and subcutaneous fat depots Horm Metab Res 34 2002 622 628
19. S.K. Fried, D.A. Bunkin, A.S. Greenberg Omental and subcutaneous adipose tissue of obese subjects release interleukin-6 Depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 83 1998 847 850
20. J. Axelsson, A.R. Qureshi, M.E. Suliman Truncal fat mass as a contributor to inflammation in end-stage renal disease Am J Clin Nutr 80 2004 1222 1229
21. L. Nordfors, F. Lönnqvist, O. Heimbürger Low leptin gene expression and hyperleptinemia in chronic renal failure Kidney Int 54 1998 1267 1275
22. J.T. Kielstein, B. Becker, S. Graf Increased resistin blood levels are not associated with insulin resistance in patients with renal disease Am J Kidney Dis 42 2003 62 66
23. R. Pecoits-Filho, O. Heimbürger, P. Barany Associations between circulating inflammatory markers and residual renal function in CRF patients Am J Kidney Dis 41 2003 1212 1218
24. P. Stenvinkel, R. Pecoits-Filho, B. Lindholm Leptin, ghrelin and proinflammatory cytokines Compounds with nutritional impact in chronic kidney disease Adv Ren Replace Ther 10 2003 332 345
25. W.A. Banks, A.B. Coon, S.M. Robinson Triglycerides induce leptin resistance at the blood-brain barrier Diabetes 53 2004 1253 1260
26. U.B. Pajvani, M. Hawkins, T.P. Combs Complex distribution, not absolute amount of adiponectin, correlates with thiazolidedione-mediated improvement in insulin sensitivity J Biol Chem 279 2004 12152 12162
27. K. Hotta, T. Funahashi, Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
28. J. Spranger, A. Kroke, M. Mohlig Adiponectin and protection against type-2 diabetes mellitus Lancet 361 2003 226 228
29. M.W. Rajala, P.E. Scherer Minireview The adipocyte--At the crossroads of energy homeostasis, inflammation, and atherosclerosis Endocrinology 144 2003 3765 3773
30. N. Ouchi, M. Ohishi, S. Kihara Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234
31. F. Zoccali, F. Mallamaci, G. Tripepi Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease J Am Soc Nephrol 13 2002 134 141
32. P. Stenvinkel, A. Marchlewska, R. Pecoits-Filho Adiponectin in renal disease relationship to phenotype and genetic variation in the gene encoding adiponectin Kidney Int 65 2003 274 281
33. Y. Okamoto, S. Kihara, N. Ouchi Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770
34. N. Ouchi, S. Kihara, Y. Arita Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signalling through a cAMP-dependent pathway Circulation 102 2000 1296 1301
35. N. Ouchi, S. Kihara, T. Funahashi Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674
36. R. Rea, R. Donnelly Resistin: An adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab 6 2004 163 170
37. C.M. Steppan, S.T. Bailey, S. Bhat The hormone resistin links obesity to diabetes Nature 409 2001 307 312
38. D. Kawanami, K. Maemura, N. Takeda Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells A new insight into adipocytokine-endothelial cell interactions Biochem Biophys Res Commun 314 2004 415 419
39. L. Patel, A.C. Buckels, I.J. Kinghorn Resistin is expressed in human macrophages and directly regulated by PPARγ activators Biochem Biophys Res Commun 300 2003 472 476
40. P. Stenvinkel, M. Ketteler, R.J. Johnson Interleukin-10, IL-6 and TNF-α important factors in the altered cytokine network of end-stage renal disease--The good, the bad and the ugly Kidney Int 2005 (in press)
41. Y. Kaizu, S. Ohkawa, M. Odamaki Association between inflammatory mediators and muscle mass in long-term hemodialysis patients Am J Kidney Dis 42 2003 295 302
42. M. Visser, L.M. Bouter, G.M. McQuillan Elevated C-reactive protein levels in overweight and obese adults JAMA 282 1999 2131 2135
43. L. Ferrucci, B.W. Penninx, S. Volpato Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels J Am Geriatr Soc 50 2002 1947 1954
44. S.S. Yeh, M.W. Schuster Geriatric cachexia The role of cytokines Am J Clin Nutr 70 1999 183 197
45. T. Cederholm, B. Wretlind, K. Hellstrom Enhanced generation of interleukins 1 beta and 6 may contribute to the cachexia of chronic disease Am J Clin Nutr 65 1997 876 882
46. T. Tsujinaka, J. Fujita, C. Ebisuri Interleukin-6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin-6 transgenic mice J Clin Invest 97 1996 244 249
47. M. Barbieri, L. Ferruci, E. Ragno Chronic inflammation and the effect of IGF-1 on muscle strength and power in older persons Am J Physiol Endocrinol Metab 284 2003 E481 E487